Spinal Simplicity earned the FDA’s 510(k) clearance for the Freedom decompression system, according to an April 23 news release.
The minimally invasive system is designed for lumbar spinal stenosis and introduces enhanced instrumentation to improve procedural precision and efficiency.
“Freedom DS was designed with precision and purpose,” Todd Moseley, CEO of Spinal Simplicity said in the release. “Every instrument is thoughtfully engineered to enhance control, helping physicians work more efficiently. Most importantly, this expands our ability to treat the right patient with the right solution, all rooted in our mission to put patients first and help them get their freedom back.”
The system will be available in a phased limited market release, and a full commercial launch is expected in 2026.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
